The supply of Acarbose Tablets has been disrupted since October 2018, when Bayer advised of issues with the supply of Glucobay Tablets.

Acarbose supply issue is not resolved.  Effective from 1 June 2019 there will be new listing of a registered product in the Pharmaceutical Schedule.

Accarb Mylan Tab 100 mg 90                Pharmacode 2402416                   Schedule price $20.23

However that is not going to resolve the supply issue immediately.

To assist with the supply PHARMAC have previously listed unregistered products as follows:-

Accard Tab 50 mg 90  (S29)                                Pharmacode 2402408                     Schedule price $10.47

Acarbose Mylan Tab 100 mg 50  (S29)                        Pharmacode  2560666       Schedule price $11.24

From 1 June 2019 PHARMAC will remove the Section 29 requirement and wastage rule for Accarb Tab 50 mg 90.

Please monitor your reimbursement for existing supply as it will retain the existing Pharmacode 2402408 which triggers the payment with Sector OP’s. There is a significant difference in the way you are reimbursed for Registered and Unregistered medicines.

While there will be a new 100 mg listing, we will not make this available until all existing supplies of the following are depleted:-

Acarbose Mylan Tab 100 mg 50  (S29)                       Pharmacode  2560666       Schedule price $11.24

We respectfully request that you continue to order only this product via the Section 29 section on our Website.

We thank you in anticipation of your ongoing support.

About The Author